Expression of epidermal growth factor receptor in breast carcinoma before and after chemotherapy and its significance

BAO Yun,WANG Wen-juan,TANG Feng,LI Qiong,XU Zu-de

2011-01-01

Abstract:Objective To assess the expression of epidermal growth factor receptor(EGFR),HER2/c-neu(ErbB-2;C-erbB-2) and other tumor metastasis and proliferation related molecules(CD 147;Ki67) before and after chemotherapy with P-glycoprotein(P-gp) substrates in breast carcinoma,so as to explore their clinical significance. Methods EGFR,C-erbB-2,CD147 and Ki67 expression were assessed in 40 tissue samples from breast carcinoma before and after short-term chemotherapy with P-gp substrates by immunohistochemistry. Results The expression of EGFR was increased after chemotherapy with P-gp substrates(80.0% vs.42.5%,P<0.01).Meanwhile,the expression of C-erbB-2,CD147 and Ki67 were decreased,but only Ki67 showed significant change(32.5% vs.85.0%,P<0.01).We also found that patients with EGFR over-expression and lack of C-erbB-2 expression(either before or after chemotherapy) were likely to have lymph node metastasis.No association was found among EGFR,C-erbB-2 and Ki67 expression,or among clinicopathologic features.Conclusions Short-term chemotherapy can kill tumor cells and decrease Ki67 proliferation,meanwhile,it can increase EGFR expression,but doesn't result in expression of CD147 and other downstream factors that cause the transfer of tumor cells.